Relmada Therapeutics (RLMD) Total Debt (2014 - 2018)

Relmada Therapeutics (RLMD) has 5 years of Total Debt data on file, last reported at $7.7 million in Q3 2018.

• Total Debt for Q3 2018 came in at $7.7 million, up 141.05% year-over-year; the trailing twelve-month figure through Sep 2018 was $7.7 million (up 141.05% YoY), and the FY2018 annual result was $6.9 million, up 3795.92% from the prior year.
• Total Debt rose to $7.7 million in Q3 2018 per RLMD's latest filing, from $6.9 million in the prior quarter.
• Over five years, Total Debt peaked at $46.8 million in Q3 2014 and troughed at $175853.0 in Q2 2017.
• A 5-year average of $9.7 million and a median of $4.8 million in 2015 frame the typical range for Total Debt.
• The sharpest annual moves came in 2016 and 2018: Total Debt sank 97.49% in 2016, then surged 3795.92% in 2018.
• A 5-year view of Total Debt shows it stood at $26.6 million in 2014, then tumbled by 94.56% to $1.4 million in 2015, then sank by 63.8% to $523505.0 in 2016, then surged by 847.68% to $5.0 million in 2017, then surged by 55.33% to $7.7 million in 2018.
• Business Quant data shows RLMD's Total Debt at $7.7 million in Q3 2018, $6.9 million in Q2 2018, and $5.5 million in Q1 2018.